Surmodics | SRDX - Выручка от реализации





Продажи Изменить Дата
Abbott USD 11.46B 90M 2025-12
Align Technology USD 1.05B 54.3M 2025-12
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
Artivion USD 115.99M 2.6M 2025-12
Baxter International USD 2.97B 130M 2025-12
Boston Scientific USD 5.29B 220M 2025-12
EDAP TMS EUR 13.88M 2.16M 2025-09
Edwards Lifesciences USD 1.57B 20M 2025-12
Haemonetics USD 338.97M 11.97M 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
J&J USD 24.6B 610M 2025-12
Merit Medical Systems USD 393.9M 9.7M 2025-12
Mesa Laboratories USD 62.84M 5.01M 2024-12
Nektar Therapeutics USD 24.12M 635K 2024-09
Option Care Health USD 1.47B 30M 2025-12
Stryker USD 7.2B 1.14B 2025-12
Surmodics USD 29.92M 96.16M 2024-12
Trinity Biotech USD 14.31M 1.55M 2025-09